Table 2 Unadjusted and adjusted OR’s for MDT decision to propose nonstandard treatment

Age

<65 years ^a

1.22

0.7–1.9

1.46

0.9–2.4

≥65 years

Gender

Male ^a

0.72

0.4–1.2

0.72

0.4–1.3

Female

Comorbidity score (ACE-27)

Low (0–1) ^a

3.06*

1.9–4.8

3.40*

2.0–5.7

High (2–3)

Tumor stage

Early (I-II) ^a

5.74*

3.0–11.0

3.40*

1.4–8.5

Advanced (III-IV)

Tumor site

Oral cavity ^a

Pharynx

2.75*

1.6–4.9

0.94

0.4–2.2

Larynx

1.69

0.9–3.3

0.85

0.3–2.1

Prior malignancy

No ^a

Other prior cancer yet treated

0.78

0.3–1.6

0.61

0.3–1.5

Prior head and neck cancer yet treated

1.60

0.8–3.1

2.56*

1.1–5.7

Marital status

Partner ^a

1.83*

1.2–2.9

1.68

1.0–2.9

Single

Children

Yes ^a

No

1.23

0.7–2.1

1.07

0.6–2.0

Unknown

0.79

0.4–1.5

1.31

0.7–2.7

No contact

0.84

0.7–1.1

0.90

0.7–1.1

Standard treatment according to guidelines

Surgery ^a

Radiotherapy

1.37

0.5–4.1

1.31

0.4–4.5

Chemoradiation

8.29*

3.2–21.5

4.79*

1.3–17.1

Surgery + radiotherapy

2.53

0.9–7.0

1.13

0.3–4.0

Surgery + chemotherapy

8.00*

1.6–39.0

4.61

0.7–29.5

Surgery + PORT on indication

0.86

0.2–3.3

0.98

0.2–4.2

Year of treatment

2010 ^a

2011

0.71

0.4–1.3

0.56

0.3–1.1

2012

1.04

0.6–1.7

1.11

0.6 2.0